Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | TYMS | P04818 | 2/20 | 0.73 |
| ▸ | POLB | P06746 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | GAA | P10253 | 1/20 | 0.73 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.73 |
| ▸ | DHFR | P00374 | 9/20 | 0.67 |
| ▸ | TLR4 | O00206 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Folic Acid SCHEMBL3878 | 1.00 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL29677832 | 1.00 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL12148554 | 1.00 | KDM4E (0.73) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL1887022 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL12497751 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL23388805 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL19837676 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL652283 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL22441084 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB | |
| Folic Acid SCHEMBL842691 | 0.99 | KDM4E (0.72) | KDM4EMEN1ALDH1A1TYMSPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103719632-A | Livestock feed containing nutlet components and livestock feeding method | WANG ZHONG | 2014-04-16 | — | — | CN | claimed |
| CN-103704534-A | Dairy cow feed containing nutlet components and method for breeding dairy cows by stages | WANG ZHONG | 2014-04-09 | — | — | CN | claimed |
| CN-103689235-A | Laying hen feed taking nuts as feed components and classified feeding method of laying hen | WANG ZHONG | 2014-04-02 | — | — | CN | claimed |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-03-03 | — | — | US | claimed |
| EP-1303311-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | Neurochem, Inc. (CA) | 2003-04-23 | — | — | EP | claimed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | claimed |
| WO-2002007781-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | NEUROCHEM INC. (CA) | 2002-01-31 | — | — | WO | claimed |
| CN-119585616-A | Biomarkers and methods for treating NSCLC | 天境生物科技(上海)有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20250051277-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2025-02-13 | — | — | US | disclosed |
| CN-113607945-B | Combination therapy of anti-HER 2 antibody-drug conjugates and Bcl-2 inhibitors | 豪夫迈·罗氏有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118715239-A | Dual cytokine fusion proteins comprising multi-subunit cytokines | 德卡生物科学公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118695868-A | Dual cytokine fusion proteins comprising IL-10 and adoptive cell therapies or dual-specific T cell adaptors for treating cancer | 德卡生物科学公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118147029-A | Engineered immunostimulatory bacterial strains and uses thereof | 阿克蒂姆治疗有限公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-2007092847-A2 | SOLID PHASE SYNTHESIS OF ACRIDINIUM DERIVATIVES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2007-08-16 | — | — | WO | disclosed |
| US-20070191352-A1 | Inhibition of tau-tau-association | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2007-08-16 | — | — | US | disclosed |
| US-20070041934-A1 | Dendrimer based compositions and methods of using the same | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-02-22 | — | — | US | disclosed |
| US-6908941-B2 | Topical applying; animal growth regulators | THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT | 2005-06-21 | — | — | US | disclosed |
| US-20040265345-A1 | Treatment of skin damage using acetyl carnitine and lipoic acid | N.V. PERRICONE LLC | 2004-12-30 | — | — | US | disclosed |
| US-20040081634-A1 | HAIR AND NAIL TREATMENTS USING ALKANOLAMINES | THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT | 2004-04-29 | — | — | US | disclosed |
| US-4087556-A | STABILIZATION WITH PHOSPHATES, CITRATES, ASCORBATES, ENCAPSULATION | CHEMISCHE INDUSTRIE RANDSTAD, N.V. (NE) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051277-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | PNMT, HNMT, NNMT | KDM4E 2549/4885MEN1 163/4885ALDH1A1 1109/4885 |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | KDM4E 3994/4885MEN1 605/4885ALDH1A1 3305/4885 |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | KDM4E 3994/4885MEN1 605/4885ALDH1A1 3305/4885 |
| US-20040265345-A1 | Treatment of skin damage using acetyl carnitine and lipoic acid | CUTA, LRAT, ACACA | KDM4E 3641/4885MEN1 4866/4885ALDH1A1 145/4885 |
| US-20070191352-A1 | Inhibition of tau-tau-association | MAPT, PSEN1, PSEN2 | KDM4E 3570/4885MEN1 4053/4885ALDH1A1 4307/4885 |
| US-20040081634-A1 | HAIR AND NAIL TREATMENTS USING ALKANOLAMINES | TYR, DNER, KRT18 | KDM4E 129/4885MEN1 2409/4885ALDH1A1 489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.